IP
BIOC

Intellectus Partners’s Biocept, Inc. BIOC Stock Holding History

Intellectus Partners’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Hold
0
– – – 556
2018
Q3 		– Hold
0
– – – 629
2018
Q2 		– Hold
0
– – – 625
2018
Q1 		– Hold
0
– – – 588
2017
Q4 		– Hold
0
– – – 585
2017
Q3 		– Sell
-1
Closed -$11.8K – 723
2017
Q2 		$17K Sell
1
-13
-93% -$184K 0.01% 534
2017
Q1 		$271K Buy
+14
New +$238K 0.14% 151
2016
Q4 		– Hold
0
– – – 651

Other funds holding BIOC

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Intellectus Partners's BIOC Position: Q4 2018 in Review

Intellectus Partners held its Biocept, Inc. (BIOC) position steady in Q4 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #556.

Intellectus Partners first reported a position in BIOC in Q1 2017 and has held it in 2 quarters since. The position peaked at $271K in Q1 2017. 13 funds tracked by Wall St. Rank hold BIOC as of Q4 2018.

  • Intellectus Partners held 0 shares of Biocept, Inc. worth $0 as of Q4 2018.
  • Intellectus Partners left its Biocept, Inc. share count unchanged in Q4 2018.
  • Biocept, Inc. made up ﹤0.01% of Intellectus Partners's portfolio in Q4 2018, its #556 holding.
  • Intellectus Partners first reported a position in Biocept, Inc. in Q1 2017 and has held it in 2 quarters since.
  • Intellectus Partners's Biocept, Inc. position peaked at $271K in Q1 2017.
  • 13 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2018.

Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.